Under Armour, INC
Market Movers (8-K)
NYSE
Under Armour announced its fourth quarter and full-year fiscal 2026 financial results, reporting a revenue decrease and providing an initial outlook for fiscal 2027 with expected gross margin improvement.
Worse than expected
NYSE
Under Armour, Inc. announced the appointment of Reza Taleghani as its new Executive Vice President and Chief Financial Officer, effective February 11, 2026.
NYSE
Under Armour reported a 5% revenue decrease in Q3 fiscal 2026, with North America declining 10%, and updated its full-year outlook with slight improvements to adjusted guidance.
Better than expected
NYSE
Under Armour announced significant executive leadership changes, including new Chief Merchandising Officer and President, Americas, to accelerate its transformation and drive sustainable growth.
NYSE
Under Armour announced an expanded restructuring plan with increased charges and the strategic separation of its Curry Brand partnership with Stephen Curry.
Worse than expected
NYSE
Under Armour reports a 5% revenue decline for Q2 Fiscal 2026, exceeding prior outlook, and announces Reza Taleghani as its new CFO, succeeding David Bergman in February 2026.
Better than expected
Quarterly Earnings (10-Q)
NYSE
Under Armour posted a significant net loss for the quarter and nine months ended December 31, 2025, driven by declining revenues, increased restructuring charges, and a major legal setback requiring repayment of $90 million in insurance proceeds.
Worse than expected
NYSE
Under Armour posted a net loss of $18.8 million in the second quarter of fiscal 2026, as net revenues fell 4.7% due to challenging market conditions and increased restructuring charges.
Worse than expected
Capital raise
NYSE
Under Armour reported a 4.2% revenue decrease in the first quarter of fiscal 2026, but significantly narrowed its net loss and improved gross margin, while addressing debt maturity and ongoing litigation.
Capital raise
Worse than expected
NYSE
Under Armour's Q3 fiscal 2025 results reveal a revenue decrease, driven by challenges in North America and Asia-Pacific, alongside ongoing restructuring initiatives aimed at improving financial efficiencies.
Worse than expected
NYSE
Under Armour's Q2 2025 results show a revenue decline but improved gross margins amidst ongoing restructuring efforts.
Worse than expected
NYSE
Under Armour's first quarter of fiscal year 2025 saw a significant net loss of $305.4 million, driven by restructuring charges and a large litigation settlement.
Worse than expected
Delay expected
Annual Reports (10-K)
NYSE
Under Armour's Form 10-K details a 3.8% decrease in net revenues for Fiscal 2026, driven by challenges in North America and Asia-Pacific, alongside a 240 basis point decline in gross margin.
Worse than expected
NYSE
Under Armour reports a 9.4% decrease in total net revenues for fiscal year 2025, driven by challenges in North America and Asia-Pacific, while implementing a restructuring plan to improve financial efficiencies.
Delay expected
Worse than expected
NYSE
Under Armour's 2024 annual report details a year of strategic focus on long-term growth, despite facing a challenging retail environment, particularly in North America.
Worse than expected
Delay expected
Capital raise
Insider Trading (Form 4)
NYSE
Under Armour Director Patrick Whitesell acquired deferred stock units valued at $0, totaling 3,912.36 units, as part of the company's 2025 Non-Employee Director Compensation Plan.
NYSE
Robert John Sweeney, a Director at Under Armour, Inc., acquired 4,303.6 Class C Common Stock units on July 1, 2026, as part of deferred director fees.
NYSE
David W. Gibbs, a Director at Under Armour, Inc., reported a transaction involving Class C Common Stock on July 1, 2026.
NYSE
Dawn N. Fitzpatrick, a Director at Under Armour, Inc., acquired 4,303.6 Class C Common Stock units on July 1, 2026, as part of deferred director fees.
NYSE
Under Armour Director Carolyn Everson acquired deferred stock units valued at $782.47 as part of the company's Fiscal Year 2025 Non-Employee Director Compensation Plan.
NYSE
Mohamed El-Erian, a Director at Under Armour, Inc., reported the acquisition of deferred stock units under the company's 2025 Non-Employee Director Compensation Plan.
Proxy Statements (Def-14A)
NYSE
Under Armour announces its 2026 Annual Meeting of Stockholders to be held virtually on August 26, 2026, detailing director elections, executive compensation votes, and incentive plan updates.
Delay expected
NYSE
Under Armour, Inc. has issued its definitive proxy materials for the 2025 Annual Meeting of Stockholders, outlining proposals for director elections, executive compensation, and auditor ratification.
NYSE
Under Armour, Inc. has filed its definitive proxy statement for the 2025 Annual Meeting of Stockholders, outlining proposals for director elections, executive compensation approval, auditor ratification, and a stockholder climate proposal, while detailing executive pay and corporate governance.
Delay expected
Better than expected
NYSE
Under Armour's 2024 Annual Meeting will address director elections, executive compensation, stock purchase plan amendments, and auditor ratification.
NYSE
Under Armour's 2024 proxy statement outlines proposals for the annual stockholder meeting, including director elections, executive compensation, and amendments to the employee stock purchase plan.
Worse than expected
Schedule 13D - Activist Investments
NYSE
Fairfax Financial Holdings and its affiliates have increased their beneficial ownership in Under Armour, Inc. to 24.0% of the outstanding Class A common stock.
NYSE
Fairfax Financial Holdings Limited and its affiliates have disclosed a significant beneficial ownership of 22.2% in Under Armour's Class A Common Stock for investment purposes.
Schedule 13G - Passive Investments
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 5.75% in Under Armour Inc. common stock as of March 31, 2026.
NYSE
The Vanguard Group has amended its Schedule 13G filing for Under Armour Inc., reporting 0% beneficial ownership following an internal realignment.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Under Armour Inc. following an internal realignment.
NYSE
The Vanguard Group updated its beneficial ownership of Under Armour Inc. common stock, reporting a 9.09% stake and detailing an internal realignment affecting portfolio management and proxy voting services.
NYSE
SCHEDULE 13G/A: Dimensional Fund Advisors Reports 3.8% Stake in Under Armour
Dimensional Fund Advisors LP has disclosed a 3.8% beneficial ownership stake in Under Armour Inc. common stock as of December 31, 2025.
NYSE
BlackRock, Inc. has reported an 8.3% beneficial ownership stake in Under Armour Inc.'s common stock, holding over 16.6 million shares.